Coherus Oncology (CHRS) Revenue Growth (3y) (2016 - 2026)
Coherus Oncology (CHRS) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Coherus Oncology | 200.42 Mn | 33.38 Mn | 8.50 Mn | -27.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.60% |
| Dec 31, 2025 | -34.49% |
| Sep 30, 2025 | -36.61% |
| Jun 30, 2025 | -44.55% |
| Mar 31, 2025 | -49.81% |
| Dec 31, 2024 | -52.76% |
| Sep 30, 2024 | -58.14% |
| Jun 30, 2024 | -51.02% |
| Mar 31, 2024 | -69.71% |
| Dec 31, 2023 | -6.06% |
| Sep 30, 2023 | -13.08% |
| Jun 30, 2023 | -24.36% |
| Mar 31, 2023 | -34.64% |
| Dec 31, 2022 | -28.46% |
| Sep 30, 2022 | -25.91% |
| Jun 30, 2022 | -10.33% |
| Mar 31, 2022 | 17.46% |
| Jun 30, 2020 | 359.33% |
| Mar 31, 2020 | 796.95% |
| Dec 31, 2019 | 427.48% |